George J. Vuturo
Nessuna posizione attualmente
Profilo
George J.
Vuturo is a Director of Zila, Inc. He was a Director of Atrix Laboratories, Inc. from 2001 to 2004 and a Member 0f the Executive, Compensation, Audit and Nomination Committee.
Dr. Vuturo has over 28 years of experience in the pharmaceuticals industry.
He was Founder and Managing Partner of Designing Solutions LLC since 1995 and Professional Education Services Group LLC since 1995.
Dr. Vuturo was a Director of QLT, Inc. from 2004 to 2005.
He received a PhD in Health Care Administration and Bachelor of Science in Pharmacy from the University of Florida and a BS in Biology from Fairfield University.
Precedenti posizioni note di George J. Vuturo
Società | Posizione | Fine |
---|---|---|
Zila, Inc.
Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Direttore/Membro del Consiglio | 18/09/2009 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | 01/08/2005 |
Atrix Laboratories, Inc.
Atrix Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Atrix Laboratories, Inc. develops and manufactures dental, medical, and veterinary products for drug delivery application | Direttore/Membro del Consiglio | 01/01/2004 |
Designing Solutions LLC | Corporate Officer/Principal | - |
Professional Education Services Group LLC | Corporate Officer/Principal | - |
Formazione di George J. Vuturo
Fairfield University | Undergraduate Degree |
University of Florida | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Atrix Laboratories, Inc.
Atrix Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Atrix Laboratories, Inc. develops and manufactures dental, medical, and veterinary products for drug delivery application | Health Technology |
Zila, Inc.
Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Designing Solutions LLC | |
Professional Education Services Group LLC |
- Borsa valori
- Insiders
- George J. Vuturo